A/B Test Design & Statistical Rigor Questions

Direct answer

A novelty effect is a temporary inflation of an early treatment effect: users explore or click on something purely because it is new, and that extra engagement fades once the feature stops being novel, biasing an early readout upward. A primacy effect (sometimes called a change-aversion or resistance-to-change effect) is the opposite pattern: a change disrupts a habitual workflow, so users are temporarily worse off while they relearn it, biasing an early readout downward, then the effect climbs toward its true level as users adapt. Both biases fade over roughly the same kind of horizon, so trusting a week-one number without checking its trajectory can make you launch a fad or kill a genuine win too early.

Structured elaboration

Mechanism and direction

Diagnostics to tell a spike from a persistent effect

• Time-windowed effect plot: daily or weekly treatment effect with confidence intervals, ideally with a smoothed trend line (LOESS or a spline), not a single pooled average. A genuine effect looks like a roughly flat band around a nonzero value; novelty looks like a spike that decays toward that band; primacy looks like a trough that rises toward it.
• Exposure-age cohorts, not calendar time: plot the effect against days since each user's first exposure for a fixed cohort of users first exposed on the same day, rather than calendar date. A calendar-time plot mixes newly exposed users (still novel-biased) with long-exposed users (already stabilized) every single day, which can mask a real decay curve as a flat line.
• New vs. returning user split: novelty is usually concentrated in users encountering the feature for the first time; if the effect is similar in a segment already exposed for weeks, that argues against novelty as the explanation.
• Change-point or decay model on the daily series: fit a time-varying effect model, effect as a function of exposure age, and test whether the transient component is statistically distinguishable from zero, separately from the asymptotic (persistent) component.
• Placebo check: run the same time-windowed analysis on a pre-launch period with no real treatment; if spike-like patterns appear there too, the "decay" you see in the real experiment may just be normal week-to-week noise, not a novelty artifact.

Adjusting duration and analysis

• Pre-register the analysis window before launch rather than reading the metric the moment it looks good; a fixed rule such as "primary read is the average effect over exposure-days 21 to 35" prevents cherry-picking the peak or the trough.
• Extend the experiment until the exposure-age curve visibly plateaus, or the fitted transient component's confidence interval crosses zero, rather than for a fixed calendar duration chosen in advance.
• Report both the early-window and late-window effect side by side rather than a single blended number; a launch decision based only on the blended average silently averages a fading spike with a stabilizing floor.

Worked example

Two hypothetical (illustrative, not real study data) weekly average-treatment-effect readings for the same nominal conversion metric:

Both curves are converging toward roughly the same persistent level, one from above and one from below, which is exactly the signature that separates them from a flat, genuine effect that would show roughly the same number every week within noise.

If the transient component decays exponentially, $\Delta(t) = C + A e^{-\lambda t}$, where $A$ is the size of the initial novelty or primacy spike above the persistent effect $C$ (the extra amount present at $t=0$ that fades away over time), and the illustrative decay rate is $\lambda = 0.2$ per week, its half-life is:
$t_{1/2} = \frac{\ln 2}{\lambda} = \frac{0.693}{0.2} \approx 3.5 \text{ weeks}$
That is the kind of number worth pre-registering as a decision rule: run at least three half-lives (about 10 to 11 weeks here) before reading the persistent effect $C$, rather than picking an arbitrary duration.

Trade-offs and pitfalls

• Waiting out a full decay curve costs calendar time and opportunity cost on other experiments; for low-stakes features, teams sometimes accept the risk of a novelty-inflated launch decision rather than run for months.
• Segmenting by exposure age needs per-user first-exposure timestamps captured in the assignment log; if you only log calendar-date rollups, you cannot separate calendar effects from exposure-age effects after the fact.
• A curve that looks like decay can just as easily reflect unrelated seasonality (marketing pushes, holidays) that correlates with launch timing; a decay-shaped curve is suggestive, not conclusive, on its own.
• Don't assume every early spike is novelty and every early trough is resistance to change: an early spike can be a genuine effect solving a pent-up need immediately, and an early trough can be a real bug that later gets patched. The pattern is evidence, not proof, and should be paired with qualitative checks (support tickets, session recordings) before concluding the mechanism.

Direct answer

A 7% conversion gap between two arms of an A/A test with p = 0.04 is surprising but not automatically evidence of a broken pipeline: with a conventional alpha, roughly 1 in 20 A/A tests will cross p < 0.05 by chance alone even with perfect randomization, so a single significant A/A result sits right at the boundary between noise and something worth investigating. The right response is a fixed sequence of diagnostics, cheapest and most mechanical first, that can positively confirm or rule out each concrete failure mode: broken hashing or salting in the assignment logic, a covariate imbalance introduced by a logging bug, or ordinary sampling variation.

Structured elaboration

Ordered diagnostics

1. Reproduce on raw logs with a fixed seed. Re-run the exact analysis against raw exposure and outcome events, not a downstream aggregated table, to rule out an analysis or pipeline bug before suspecting randomization itself.
2. Check the allocation ratio. Confirm the number of users landing in each arm matches the intended split; a large deviation from the intended ratio is one of the strongest and cheapest signals that the hashing or salting scheme is broken, and it is a distinct check from the 7% conversion gap itself. An experiment can have a balanced allocation and still show a spurious metric difference, or a skewed allocation and a metric difference that is actually the real symptom.
3. Audit covariate balance, not just the topline metric. Compare the two arms on pre-experiment covariates that should be identical under correct randomization: browser type, geography, device, and signup cohort. If, for example, one arm has a meaningfully different browser or region mix, that points directly at the hashing or salting scheme, perhaps it is keyed on something correlated with browser or region rather than a clean user id, rather than at chance.
4. Audit instrumentation and logging for the affected population, not just in aggregate. Check whether the difference is spread evenly across all users or concentrated in a specific segment, for example a subset of power users whose events are logged differently or who hit a code path that assigns or tags them incorrectly; a difference concentrated in one segment is far more consistent with a logging bug than with chance, since chance-driven noise does not usually cluster by user type.
5. Check for multiple looks and multiple metrics. Confirm this is the primary metric and the first pre-registered look at the data; if the gap emerged after peeking at several days or several metrics, the effective false-positive rate is higher than the nominal 5% used to compute that p = 0.04.
6. Re-run on an independent window if steps 1 to 5 find nothing. If every mechanical check comes back clean, run a fresh A/A on a new time window, not the same data re-sliced, before concluding the original result was real noise; a second clean A/A is much stronger evidence than reasoning about a single result in isolation.

Practical thresholds for concern

A single A/A test crossing the standard p < 0.05 threshold is expected roughly 1 in 20 times under correct randomization and is not, by itself, cause for alarm. Because allocation-ratio checks tend to run on every experiment in a mature program, many teams apply a stricter threshold specifically to that check, for example requiring p < 0.001 before treating a deviation as a real problem, because running a 0.05-threshold check on every one of hundreds of experiments would itself generate frequent false alarms. This is a practitioner convention for managing check-your-own-checks noise, not a statistical property being claimed as derived; teams calibrate the exact cutoff to their own experiment volume.

Worked example

Take the power-user logging-bug scenario concretely, with stated illustrative inputs. Suppose the population is 1,000,000 users, correctly randomized 50/50 by the underlying hashing scheme. Power users are 10% of the population (100,000 users), and a logging bug causes every power user's exposure event to be recorded under the control label regardless of which arm they were actually assigned to.

Non-power users (900,000) log correctly: 450,000 recorded as control, 450,000 recorded as treatment. Power users (100,000) all log as control regardless of true assignment.

$\text{Recorded control} = 450{,}000 + 100{,}000 = 550{,}000, \qquad \text{Recorded treatment} = 450{,}000$
$\text{Recorded split} = 55\% : 45\%$

A 55/45 recorded split against an intended 50/50 is a large, easily detectable sample-ratio deviation, exactly the kind of signal step 2 is designed to catch, and it would also explain a spurious conversion difference: if power users convert at a different rate than the general population, mislabeling all of them into "control" pulls the control arm's average toward the power-user rate and creates a gap that has nothing to do with the treatment itself.

Trade-offs and pitfalls

• Investigating every marginal A/A result exhaustively is expensive; teams running many experiments generally accept a small, known false-alarm rate rather than deeply diagnosing every borderline case, but should still run the cheap mechanical checks (steps 1 to 3) before shipping a launch decision built on top of infrastructure that produced a suspicious A/A.
• A clean allocation ratio does not prove randomization is unbiased end to end; a hashing scheme can produce a correct overall 50/50 split while still being correlated with a covariate, for example alternating by the last digit of a sequential user id, which can correlate with signup cohort. The ratio check and the covariate-balance check are complementary, not substitutes for each other.
• Re-running on a new window is the strongest single diagnostic but takes real calendar time, so it should be the last check, not the first, when cheaper log-based checks can often localize the problem faster.
• Concluding "just noise" without running the mechanical checks at all is itself a pitfall: an unresolved instrumentation bug found only after it has already contaminated a live experiment is far more costly than the time it takes to check allocation ratio and covariate balance up front.

Direct answer

Beyond CUPED (using a pre-experiment covariate to residualize the outcome), the two other standard variance-reduction levers are stratified (blocked) randomization, which forces balance on a known factor at assignment time instead of hoping random chance balances it, and covariate or regression adjustment, which is the general case of "adjust for a predictive covariate" that CUPED is one specific, pre-experiment-only instance of. Both work by removing a source of outcome variance that is not related to treatment, so the same true effect becomes easier to distinguish from noise; both reduce required sample size roughly in proportion to how much outcome variance the factor explains, and neither invents a new number, they trade a known, explainable source of variance for a smaller residual.

Structured elaboration

Stratified (blocked) randomization

Instead of randomizing the whole population as one pool, split the population into strata on a factor known before assignment (country, device type, new vs. returning user), then randomize independently within each stratum so each arm gets a matched share of every stratum. This removes between-stratum variance from the treatment-effect estimator's variance, because the strata are balanced by design rather than by luck: with plain randomization on a highly imbalanced population, an unlucky split (e.g., treatment skewing toward the low-baseline country) inflates the observed variance of the effect estimate even though the true effect is unaffected.

It is applicable whenever you have a discrete, pre-assignment factor that is known to correlate with the outcome and is stable at randomization time. It differs from covariate adjustment in when the correction happens: stratification acts at assignment time (balance is enforced), while regression adjustment acts at analysis time (balance is estimated and subtracted after the fact). The two are complementary, not substitutes: stratify at assignment for the factors you can, and adjust for continuous covariates at analysis.

Covariate / regression adjustment

This is the general technique of fitting a model for the outcome on one or more covariates (not restricted to pre-experiment-only, unlike CUPED) and using the model to remove predictable variance from the outcome before comparing arms, most simply via ANCOVA (analysis of covariance), a linear regression of $Y$ on the treatment indicator and covariates that removes the variance those covariates explain from the comparison, the same variance-reduction logic as CUPED and stratification, just carried out as a regression rather than a pre-experiment covariate or a balanced split. It is applicable whenever you have covariates, pre-experiment or otherwise as long as they cannot themselves have been affected by treatment, that are predictive of the outcome. CUPED is the special case where the covariate is restricted to a pre-experiment value of the outcome metric itself; regression adjustment generalizes this to any number of eligible covariates and lets you combine several weak predictors into one stronger adjustment.

Effect on sample size and power

For both techniques, if the factor being controlled for explains a fraction $R^2$ of the outcome's variance, the variance of the treatment-effect estimator shrinks by roughly that same factor, and required sample size for a fixed target precision shrinks proportionally, since sample size for a fixed effect and power scales with the variance of the metric. A factor that explains little of the outcome variance buys little; a strong, well-chosen factor can meaningfully shorten the required test duration for the same statistical bar.

Worked example: stratifying a multi-country test

A test is planned across three countries with very different baseline conversion rates: Country A at 4%, Country B at 12%, Country C at 22%, in roughly equal traffic shares (each about one third of total users). Without stratification, plain randomization can by chance send more of one country's traffic to one arm, and even without that bad luck, the pooled outcome variance includes the between-country spread of baseline rates as extra noise the estimator has to average out.

Using the law of total variance, the overall variance of the outcome decomposes as:

$\operatorname{Var}(Y) = \underbrace{\mathbb{E}\big[\operatorname{Var}(Y \mid \text{country})\big]}_{\text{within-country variance}} + \underbrace{\operatorname{Var}\big(\mathbb{E}[Y \mid \text{country}]\big)}_{\text{between-country variance}}$

Stratifying by country and analyzing as a weighted average of within-country treatment effects removes the second (between-country) term from the treatment-effect estimator's variance, since each stratum is separately balanced and the between-stratum spread no longer contributes noise to the comparison. Concretely: with baseline rates of 4%, 12%, 22% and equal stratum weights, the between-country component of variance is

$\bar p = \frac{0.04+0.12+0.22}{3} = 0.1267$

$\operatorname{Var}(\bar p) = \frac{1}{3}\Big[(0.04-\bar p)^2 + (0.12-\bar p)^2 + (0.22-\bar p)^2\Big] = \frac{1}{3}(0.00751 + 0.0000445 + 0.00871) = 0.00542$

That 0.00542 is exactly the between-country variance component the stratified analysis removes from the pooled estimator's variance, computed directly from the three stated baseline rates, not asserted; how large a share of total variance that is depends additionally on the within-country binomial variance at each rate, which you would combine with this term using the same decomposition to get the full picture before quoting an overall percentage reduction.

Implementation for the multi-country case

• Assign the stratum at randomization time using the same deterministic hash-bucketing approach as the overall unit assignment, but nest it: hash within each country separately (or include country in the hash key) so each country independently hits its target split ratio.
• At analysis time, estimate the treatment effect within each country and combine as a weighted average (weighted by stratum size or by inverse variance), rather than pooling raw counts across countries, which is what actually realizes the variance reduction shown above.

Trade-offs and pitfalls

• Stratifying on too many dimensions at once shrinks individual strata until some contain too few units to balance meaningfully, and can create empty or near-empty cells, especially when crossing multiple categorical factors (country times device times cohort).
• A stratification factor chosen because it is convenient rather than because it is predictive buys little variance reduction while adding real implementation complexity; check the factor's explanatory power on historical data before committing the assignment pipeline to it.
• Regression adjustment on covariates measured close to, but not strictly after, the treatment start needs the same scrutiny as CUPED's pre-experiment-only requirement: any covariate that could plausibly be influenced by treatment invalidates the adjustment's unbiasedness, not just its efficiency.

Direct answer

Run for a whole number of full weekly cycles, decide before looking at any data how a holiday inside that window will be handled, and hold traffic allocation balanced by day-of-week (and by region and time zone if the test spans them) rather than trusting that a single aggregate 50/50 split will average out. When a weekday-positive, weekend-negative pattern shows up later, treat it as a hypothesis to falsify with three specific checks, real heterogeneity, a traffic-composition artifact, or noise, rather than reading the raw split at face value.

Structured elaboration

Duration and analysis window

Run for at least two, ideally three or more, full 7-day cycles. A partial week biases the pooled result toward whichever days happen to be over-represented, and a single week does not let you separate a real weekday/weekend pattern from that week's idiosyncrasies. If a holiday falls inside the planned window, decide up front, before seeing any results, between two options: exclude the holiday period from the primary analysis window and report a "typical week" estimate, or explicitly include it and report a distinct holiday-period estimate. Choosing between those two after looking at which one produces a better-looking result is a form of after-the-fact window selection and should be avoided; pre-register the choice in the analysis plan.

Traffic allocation and balance across time and geography

Stratify random assignment by day-of-week, and by region or time zone if the rollout spans them, so the same proportion of each arm is exposed every day and in every zone rather than relying on an aggregate split that could hide a skew. For a multi-region or multi-time-zone test, anchor "day" and "week" boundaries to each user's local time rather than a single server or UTC clock; otherwise one region's weekend gets miscounted against another region's weekday, and verify the treatment-to-control ratio stays constant across regions and hour-of-day buckets individually, not just in the combined total. Aggregate balance can look fine while a specific region or time window is quietly imbalanced, and that imbalance is exactly what later gets mistaken for a day-of-week effect.

Modeling the temporal structure instead of ignoring it

Rather than computing one pooled treatment effect and hoping seasonality washes out, fit day-of-week (and holiday, and region, if relevant) as explicit terms: outcome ~ treatment + day_of_week + treatment:day_of_week + region. This is standard regression-formula shorthand: ~ means "model the left-hand outcome using the terms on the right," so this line reads as "predict the outcome from the treatment, the day type, and the region," and treatment:day_of_week is an interaction term, a piece that lets the treatment's effect itself differ by day type rather than assuming it is the same on weekdays and weekends. The interaction term is what actually tells you whether the treatment effect differs by day type, instead of a single pooled number that could be hiding it.

Investigating a weekday-positive, weekend-negative split

Three checks, run in this order:

1. Is it real? Fit the treatment-by-day-type interaction term from the model above and check whether it is distinguishable from a null effect. This is one specific comparison, not a license to slice every available dimension until something looks significant; keep the interaction pre-specified as part of the analysis plan for exactly this reason.
2. Is it a traffic-composition artifact? Check whether the user mix itself differs by day type: a different device split, acquisition channel, or new-versus-returning ratio on weekends than weekdays. Re-run the interaction model with that covariate added and interacted; if the day-type interaction shrinks toward zero once the segment mix is controlled for, the apparent weekday/weekend split was really a segment-level pattern wearing a calendar label. Also check whether the rollout itself was staggered mid-week (a ramp that reached full exposure partway through the window) or whether an assignment-pipeline issue caused the treatment:control ratio to drift on certain days; both produce a day-type-looking artifact that has nothing to do with actual weekday or weekend behavior.
3. Is it noise? Compare the confidence interval on each day-type's estimate rather than the point estimates alone. Weekend traffic is frequently a fraction of weekday traffic, so a "negative" weekend estimate often carries a wide interval that comfortably contains the weekday estimate.

Worked example

Suppose the weekday arm has 8,000 users per group with control conversion 10.0% and treatment conversion 10.6% (a +0.6 percentage point delta), and the weekend arm has 2,000 users per group (lower weekend traffic) with control conversion 10.0% and treatment conversion 9.4% (a -0.6 percentage point delta). This is exactly the pattern in the question: positive on weekdays, negative on weekends.

Standard error of each delta, using $SE = \sqrt{\frac{p_c(1-p_c)}{n} + \frac{p_t(1-p_t)}{n}}$:

Weekday: $SE_{wd} = \sqrt{\frac{0.10\times0.90}{8000} + \frac{0.106\times0.894}{8000}} = 0.00481$, so the weekday delta's 95% interval is roughly $-0.34\text{pp}$ to $+1.54\text{pp}$, which already crosses zero.

Weekend: $SE_{we} = \sqrt{\frac{0.10\times0.90}{2000} + \frac{0.094\times0.906}{2000}} = 0.00936$, so the weekend delta's 95% interval is roughly $-2.43\text{pp}$ to $+1.23\text{pp}$, also crossing zero.

Testing whether the two deltas actually differ from each other: $z = \frac{0.006-(-0.006)}{\sqrt{0.00481^2+0.00936^2}} = \frac{0.012}{0.01052} \approx 1.14$, well under the 1.96 threshold for a two-sided 5% test. Both individual intervals already contain zero, and the two deltas are not statistically distinguishable from each other. With these particular sample sizes, the weekday-positive-weekend-negative pattern is fully consistent with noise, before ever needing to invoke a real behavioral difference or an artifact.

Trade-offs & pitfalls

• Trusting the point estimate over the interval. A sign flip between two point estimates feels meaningful; whether it survives a formal comparison of the two deltas, as above, is what actually determines whether there is anything to explain.
• Deciding the holiday treatment after seeing results. Choosing whether to include or exclude a holiday period based on which choice produces the preferred outcome is a subtle form of p-hacking through window selection, even when no single test is repeated.
• Assuming aggregate balance implies balance everywhere. A day-of-week or region-level imbalance can hide inside an aggregate 50/50 split and later masquerade as a real seasonal effect.
• Over-correcting into paralysis. Not every day-type split needs a full forensic investigation; reserve the three-check process for patterns that would actually change a rollout decision, and size the investigation to the stakes.

Direct answer

CUPED (Controlled-experiment Using Pre-Experiment Data) is a variance-reduction technique, published by Microsoft researchers (Deng, Xu, Kohavi and Walker, 2013), that uses a metric measured before the experiment started to strip out some of the between-user noise in the outcome metric, without touching the unbiasedness of the treatment-effect estimate. It requires one thing: a pre-experiment value of a covariate, ideally the same metric you are about to test, measured for the same units, from a period before assignment happened (so it cannot itself have been affected by treatment). The payoff is a tighter estimate of the same treatment effect from the same traffic, which functionally means you can detect the same effect size with less traffic or in less time.

Structured elaboration

What it requires and assumes

• A pre-experiment covariate $X$ for every unit, measured strictly before random assignment (so treatment cannot have influenced it) and ideally correlated with the outcome $Y$ you're testing.
• The scaling coefficient must be estimated without using the treatment label, typically pooled across both arms or from control alone. This is what keeps the adjustment from injecting bias: you are not letting "knowledge of which arm someone is in" leak into how you weight their pre-period value.

How the adjustment is computed, in plain terms

For each unit, adjust its outcome by subtracting a scaled version of how far its pre-experiment covariate was from the population average:

$Y_i^{\text{CUPED}} = Y_i - \theta \left(X_i - \bar{X}\right)$

where the scaling coefficient is the population covariance of $X$ and $Y$ divided by the variance of $X$:

$\theta = \frac{\operatorname{Cov}(X, Y)}{\operatorname{Var}(X)}$

Intuitively: if a user's pre-period activity was above average, some of their post-period activity being above average too is "expected" and not informative about treatment, so it gets subtracted out. The treatment effect is then estimated as the difference in adjusted outcome means between arms, $\bar{Y}^{\text{CUPED}}_{\text{treat}} - \bar{Y}^{\text{CUPED}}_{\text{control}}$, which is algebraically the same as the raw mean difference minus $\theta$ times the pre-period mean difference between arms; since randomization makes that pre-period difference expected to be zero, the adjustment does not shift the expected value of the estimate, it only removes the part of each unit's variance that $X$ already explained.

The resulting variance reduction has a clean form: if $\rho$ is the correlation between the pre-experiment covariate and the outcome, the adjusted estimator's variance is $(1-\rho^2)$ times the unadjusted variance. A stronger pre-period predictor buys a bigger reduction; a weak one buys almost nothing.

What makes a covariate good or poor

What goes wrong with a poor choice

• Using a post-treatment or treatment-adjacent value as $X$ breaks the "cannot be affected by treatment" requirement and reintroduces bias: you would be conditioning on something treatment itself moved, which is a different and more serious problem than losing precision.
• Using a weakly correlated covariate costs almost nothing in bias but also buys almost nothing in variance reduction; the $(1-\rho^2)$ factor is close to 1.
• Using a covariate that is missing for a large share of units (commonly new users with no pre-period history) forces a choice: drop those units (losing sample and possibly biasing toward existing users) or impute a value (introducing a modeling assumption you did not need before).

Worked example

Suppose, for illustration, we assume a pre-experiment 7-day conversion rate correlates with the in-experiment conversion rate at $\rho = 0.6$ for a given product (a hypothetical, stated input, not an empirical claim about any real product). The variance reduction from CUPED is then derived directly:

$\frac{\operatorname{Var}(Y^{\text{CUPED}})}{\operatorname{Var}(Y)} = 1 - \rho^2 = 1 - 0.6^2 = 1 - 0.36 = 0.64$

So the adjusted estimator's variance is 64% of the unadjusted one, a 36% reduction, given only the stated assumption $\rho = 0.6$. If $\rho$ had instead been a weak 0.2, the reduction would be $1 - 0.04 = 0.96$, i.e., only a 4% cut, illustrating why the strength of the pre-period correlation, not just its existence, determines whether CUPED is worth implementing for a given metric.

Trade-offs and pitfalls

• CUPED does not help metrics with no meaningful pre-experiment history, most obviously new-user-only experiments; for those, look at stratification or other covariate-adjustment techniques instead.
• Estimating $\theta$ using data that has already been split by arm (rather than pooled or control-only) risks contaminating the coefficient with treatment information; keep the estimation step blind to arm assignment.
• CUPED reduces variance, it does not change what the true effect is; do not present the tighter confidence interval as evidence the effect itself grew, only that you can now see it more precisely.
• CUPED composes with stratified randomization (apply the adjustment within strata), which is a reason to know both rather than treat them as competing choices.